The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Lignende værker

• The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
  af: Donghee Kim, et al.
  Udgivet: (2025-04-01)
• Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
  af: Donghee Kim, et al.
  Udgivet: (2025-04-01)
• Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
  af: Pojsakorn Danpanichkul, et al.
  Udgivet: (2025-01-01)
• Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
  af: Donghee Kim, et al.
  Udgivet: (2024-10-01)
• Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United States
  af: Donghee Kim, et al.
  Udgivet: (2025-07-01)